Cannabidiol (CBD) shows promise in regulating appetite, glucose and lipid metabolism, and inflammation in preclinical models ...

Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specialising in the development of treatments for brain and peripheral diseases involving the CB1 receptor, ...

A new study shows that prenatal disruption of the endocannabinoid system can have long-lasting effects on brain structure and ...

Endocannabinoids are similar to the cannabinoids present in cannabis, but they are found naturally in the body. Endocannabinoids—and cannabinoids—work through a signaling system that supports ...

A new study reveals a surprising link between cannabis use and type 2 diabetes. Researchers at the European Association for ...

The American Veterinary Medical Association (AVMA) has published an updated report on cannabis and pets, focusing on the ...

On Friday, Skye Bioscience, Inc. (NASDAQ:SKYE) announced the presentation of results from the Phase 1b study of nimacimab in ...

SKNY transaction strengthens MIRA pipeline with SKNY-1, a differentiated oral candidate that has demonstrated up to 30% ...

People who use cannabis are four times more likely to develop type 2 diabetes than people who do not use it, a new study has ...

Harmony Biosciences Holdings faces setbacks after a failed trial and sNDA rejection. Click here to find out why HRMY is a ...

This article was reviewed by Lynn Marie Morski, MD, JD. When you think about weed’s effects, things like mood changes, ...

Detailed price information for Anebulo Pharmaceuticals Inc (ANEB-Q) from The Globe and Mail including charting and trades.